Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of Cancer|February 18, 2011
Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid TumorsAung Naing, James M Reuben, Luis H Camacho, et al.Cancer|June 22, 2010
A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Siqing Fu, Chaan Ng, et al.Cancer Chemotherapy and Pharmacology|November 13, 2008
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanomaKevin B Kim, Wen-Jen Hwu, Nicholas E Papadopoulos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
A phase I clinical trial of darinaparsin in patients with refractory solid tumorsApostolia Maria Tsimberidou, Luis H Camacho, Srdan Verstovsek, et al.European Journal of Cancer (Oxford, England : 1990)|September 15, 2015
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumabZeynep Eroglu, Dae Won Kim, Xiaoyan Wang, et al.Journal of Cancer|August 19, 2017
A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic CancerLee S Schwartzberg, Francis P Arena, Bryan J Bienvenu, et al.Cancer|April 28, 2007
Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liverLuis H Camacho, Razelle Kurzrock, Alex Cheung, et al.Annals of Surgical Oncology|March 16, 2006
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous diseaseTimothy M Pawlik, Daria Zorzi, Eddie K Abdalla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206Antoni Ribas, Luis H Camacho, Gabriel Lopez-Berestein, et al.The Lancet. Infectious Diseases|August 11, 2019
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trialKathleen M Mullane, Vicki A Morrison, Luis H Camacho, et al.Pageof 4